Benzinga | Feb 25, 2021 04:54PM EST

GenMark Diagnostics Q4 EPS $(0.05) Misses $(0.01) Estimate, Sales $50.08M Beat $47.13M Estimate

GenMark Diagnostics (NASDAQ:GNMK) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $(0.01) by 400 percent. This is a 70.59 percent increase over losses of $(0.17) per share from the same period last year. The company reported quarterly sales of $50.08 million which beat the analyst consensus estimate of $47.13 million by 6.26 percent. This is a 84.14 percent increase over sales of $27.20 million the same period last year.